Presentation is loading. Please wait.

Presentation is loading. Please wait.

2005 National Immunization Survey Stephen L. Cochi, M.D., M.P.H. Acting Director National Immunization Program, CDC National Press Club July 27, 2005 Department.

Similar presentations


Presentation on theme: "2005 National Immunization Survey Stephen L. Cochi, M.D., M.P.H. Acting Director National Immunization Program, CDC National Press Club July 27, 2005 Department."— Presentation transcript:

1 2005 National Immunization Survey Stephen L. Cochi, M.D., M.P.H. Acting Director National Immunization Program, CDC National Press Club July 27, 2005 Department of Health and Human Services Centers for Disease Control and Prevention

2 Vaccines are one of the most important tools we have to protect the health of our nation's most vulnerable citizens, our children.

3 Vaccines are Highly Cost Effective  DTaP saves................$27.00  MMR saves................$26.00  Perinatal Hep B saves.......$14.70  Varicella saves.............$ 5.40  Inactivated Polio (IPV) saves..$ 5.45 *direct and indirect savings (including work loss, death, and disability) For every $1 spent*:

4 Childhood Immunization Program Successes  Vaccine-preventable diseases at an all time low  Record high coverage rates  Measles is no longer endemic in the U.S. and Western Hemisphere  Rubella Eliminated

5 Immunization is one of the most important ways parents can protect their children against serious diseases.

6 Comparison of 20 th Century Annual Morbidity and Current Morbidity, Vaccine-Preventable Diseases (pre-1990 Vaccines) Disease 20th Century Annual Morbidity † 2004* Percent Decrease Smallpox48,1640100% Diphtheria175,8850100% Measles503,2823799.99% Mumps152,20923699.84% Pertussis147,27118,95787.13% Polio (paralytic)16,3160100% Rubella47,7451299.97% Congenital Rubella Syndrome8230100% Tetanus1,3142797.95% † Source: CDC. MMWR April 2, 1999. 48: 242-264 *Provisional 2004 Data Numbers in yellow indicate at or near record lows in 2004

7 Comparison of Pre-Vaccine Era Estimated Annual Morbidity and Current Morbidity, Vaccine-Preventable Diseases (post-1990 Vaccines) Disease Pre-Vaccine Era Estimated Annual Morbidity2003 Percent Decrease Hepatitis A117,33332,71172.1% Hepatitis B (acute)66,23221,03068.2% Hib (invasive)20,0004099.8% Pneumococcus (invasive)63,06739,80036.9% Varicella4,085,120817,02480.0% Influenza (<5 years)N/A --- Meningococcus (invasive)2,183N/A--- N/A = not available

8 We now have the means to protect our nation’s children against 13 diseases that in the past caused great suffering, disability and premature death. We now have the means to protect our nation’s children against 13 diseases that in the past caused great suffering, disability and premature death.

9 Number of Vaccines in the Routine Childhood Immunization Schedule 1985 (7)1995 (10)2005 (13) Measles Rubella Mumps Diphtheria Tetanus Pertussis Polio Hib (infant) HepB Varicella Pneumococcal Disease Influenza Meningococcal Measles Rubella Mumps Diphtheria Tetanus Pertussis Polio Hib (infant) HepB Varicella Measles Rubella Mumps Diphtheria Tetanus Pertussis Polio

10 Pertussis-related Deaths that have been Reported to CDC This Year Pertussis-related Deaths that have been Reported to CDC This Year 1. A 52-day-old African-American male from MS. 2. An infant from MT. 3. A 2-month-old Native American female from NM. 4. A 6-week-old infant from OR. 5. A 96-day-old, white female from WI. 6. A 4-week-old, white Hispanic female from CA. 7. A 2-month-old, white Hispanic male from CO. 8. A 27-day-old white female infant from NC. 9. A 29-day-old female infant from AZ. 10. A 3-month-old African-American male infant from FL. 11. A 13-day-old Hispanic male infant from CA. 12. A 14-day-old Hispanic female from CA. 13. A 16-week-old white male from IL. 14. A 36-day-old white male from WI. 15. A White male infant from Jefferson Parish, LA

11 Vaccines on the Horizon New Vaccine/IndicationTimeframe Meningococcal conjugate (adolescents)February 2005 TDaP (adolescents/adults)June 2005 Rotavirus (infants)February 2006 MMRV2006 2 nd dose of varicella2006 Varicella to prevent zoster2006 Universal hepatitis A2006 Human Papillomavirus (adolescents)2006 Expanding influenza vaccine use2006

12 Vaccine-Specific Coverage Rates Among Pre-school Aged Children † DTP(3+) is not a Healthy People 2010 objective. DTP(4) is used to assess Healthy People 2010 objectives. Note: Children in the USIS and NHIS were 24-35 months of age. Children in the NIS were 19-35 months of age. Source: USIS (1967-1985), NHIS (1991-1993) CDC, NCHS, and NIS (1994-December 2003), CDC, NIP and NCHS; No data from 1986-1990 due to cancellation of USIS because of budget reductions0

13 VT 85 8181 Estimated Vaccination Coverage with the 4:3:1:3:3* Series, by Coverage Level and State National Coverage = 81% *4+DTP, 3+Polio, 1+MCV, 3+Hib, 3+HepB 83 79 81 80 83 82 79 84 82 86 79 77 81 78 84 68 71 83 82 75 81 79 78 89 85 82 80 81 87 86 78 85 82 86 82 75 72 73 NJ CT MA NH RI DC DE MD 86 89 87 88 83 86 80 83 80-89% 70-79%  69%  90%

14 Percent Estimated Vaccination Coverage with Series Among Children 19-35 Months of Age, National Immunization Survey, 2000 & 2004

15 Percent Estimated Vaccination Coverage with Series Among Children 19-35 Months of Age, National Immunization Survey, 2000 - 2004

16 Challenges  Introducing new vaccines  Establishing and maintaining a steady vaccine supply  Vaccine financing  Reducing remaining racial/ethnic disparities in coverage  Addressing unfounded fears about vaccine safety

17 Estimated Vaccination Coverage* Among Children 19-35 Months of Age by Race/Ethnicity† – US, National Immunization Survey, 2000-2004 4:3:1:3:3‡ * Estimate=NA (Not Available) if the unweighted sample size for the numerator was 0.5 or (CI half width)>10 †Self-reported by respondent. Individual racial groups do not include Hispanic children. Children of Hispanic ethnicity may be of any race ‡4 or more doses of DTP, 3 or more doses of poliovirus vaccine, 1 or more doses of any MCV, 3 or more doses of Hib, and 3 or more doses of HepB

18 Children Receiving Autism Services by Quarter, California, 2002-2005 California Department of Developmental Services

19 Summary  Record high coverage rates  2010 goal of 80% vaccination series complete by age 2 years already achieved  More needs to be done to sustain the immunization system and protect more children Protecting our Children

20 Department of Health and Human Services Centers for Disease Control and Prevention

21 Estimated Vaccination Coverage with Series Among Children 19-35 Months of Age, National Immunization Survey, 2000 & 2004 2000 2000 2001 2001 2002 2002 2003 2003 2004 2004 Vaccine % (95% CI) 4:3:177.6 (±0.9)78.6 (±0.9)78.5 (±1.0)82.2 (±0.9)83.5 (±0.9) 4:3:1:376.2 (±0.9)77.2 (±0.9)77.5 (±1.0)81.3 (±0.9)82.5 (±0.9) 4:3:1:3:372.8 (±0.9)73.7 (±0.9)74.8 (±1.0)79.4 (±0.9)80.9 (±0.9) 4:3:1:3:3:154.1 (±1.0)61.3 (±1.0)65.5 (±1.1)72.5 (±1.0)76.0 (±1.0)

22 Estimated Vaccination Coverage with Individual Vaccines Among Children 19-35 Months of Age, National Immunization Survey, 2002 & 2003 2000 2000 2001 2001 2002 2002 2003 2003 2004 2004 Vaccine % (95% CI) DTP/DT/DTaP ≥3 doses94.1 (±0.5)94.3 (±0.5)94.9 (±0.6)96.0 (±0.5)95.9 (±0.5) ≥4 doses81.7 (±0.8)82.1 (±0.8)81.6 (±0.9)84.8 (±0.8)85.5 (±0.8) Poliovirus89.5 (±0.6)89.4 (±0.7)90.2 (±0.7)91.6 (±0.7) Hib ≥3 doses93.4 (±0.5)93.0 (±0.6)93.1 (±0.6)93.9 (±0.6)93.5 (±0.6) MMR ≥1 dose90.5 (±0.6)91.4 (±0.6)91.6 (±0.7)93.0 (±0.6) Hepatitis B ≥3 doses90.3 (±0.6)88.9 (±0.7)89.9 (±0.7)92.4 (±0.6) Varicella ≥1 dose67.8 (±0.9)76.3 (±0.8)80.6 (±0.9)84.8 (±0.8)87.5 (±0.7) PCV ≥3 doses -- 40.8 (±1.1)68.1 (±1.0)73.2 (±1.0) ≥4 doses -- 35.8 (±1.0)43.4 (±1.1)

23 Estimated Vaccination Coverage* Among Children 19-35 Months of Age by Race/Ethnicity† – US, National Immunization Survey, 2000-2004 4:3:1:3:3‡ 2000 2000 2001 2001 2002 2002 2003 2003 2004 2004 Vaccine % (95% CI) US National72.8 (±0.9)73.7 (±0.9)74.8 (±1.0)79.4 (±0.9)82.5 (±0.9) White only, non-Hispanic 76.1 (±1.1)75.4 (±1.1)77.7 (±1.2)82.5 (±1.1)85.1 (±1.1) Black only, non-Hispanic 67.8 (±2.7)67.2 (±2.8)67.7 (±3.1)73.0 (±3.2)76.0 (±3.0) Hispanic68.5 (±2.2)74.1 (±2.0)72.7 (±2.4)77.0 (±2.1)81.2 (±2.0) * Estimate=NA (Not Available) if the unweighted sample size for the numerator was 0.5 or (CI half width)>10 †Self-reported by respondent. Individual racial groups do not include Hispanic children. Children of Hispanic ethnicity may be of any race ‡4 or more doses of DTP, 3 or more doses of poliovirus vaccine, 1 or more doses of any MCV, 3 or more doses of Hib, and 3 or more doses of HepB


Download ppt "2005 National Immunization Survey Stephen L. Cochi, M.D., M.P.H. Acting Director National Immunization Program, CDC National Press Club July 27, 2005 Department."

Similar presentations


Ads by Google